Showing results (661-670 of 1,105) with videos related to
Sort By:
Pageof 111
Science (New York, N.Y.)|July 15, 1994
Fibrous mini-collagens in hydra nematocystsT W Holstein, M Benoit, G V Herder, et al.Neurogastroenterology and Motility|January 8, 2009
The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motilityT Edholm, K Cejvan, S M Abdel-Halim, et al.European Journal of Clinical Pharmacology|January 1, 1990
Influence of carvedilol and propranolol on coronary blood flowH Sievert, G Frey, R Schräder, et al.Neuroimage|September 6, 2016
Dynamic changes of resting state connectivity related to the acquisition of a lexico-semantic skillL Schlaffke, L Schweizer, N N Rüther, et al.Der Unfallchirurg|September 25, 2001
[Selection of subjects: a problem of clinical trials in traumatology. Selection effects and the problem of representation as exemplified by a prospective randomized trial on whiplash injuries]M Schnabel, T Schmidt, S Tuschen, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|October 31, 2001
The effect of the vasoactive intestinal polypeptide agonist Ro 25-1553 on induced tone in isolated human airways and pulmonary arteryD T Schmidt, E Rühlmann, B Waldeck, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|May 20, 2005
[Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?]C Hohl, P Haage, G A Krombach, et al.Plos One|February 8, 2022
Is it best to add native shrubs to a coastal sage scrub restoration project as seeds or as seedlings?Kylie D F McGuire, Katharina T Schmidt, Priscilla Ta, et al.British Journal of Pharmacology|January 5, 2001
The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airwaysD T Schmidt, N Watson, G Dent, et al.European Journal of Gastroenterology & Hepatology|January 28, 2005
Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YYPeter T Schmidt, Tryggve Ljung, Bolette Hartmann, et al.Pageof 111